-

Kaskela Law LLC Announces Shareholder Lawsuit Against BTRS Holdings Inc. (BTRS) in Connection with Proposed Sale of the Company at $9.50 Per Share

PHILADELPHIA, PA--(BUSINESS WIRE)--Kaskela Law LLC announces that a shareholder lawsuit has been filed against BTRS Holdings Inc. (“Billtrust” or the “Company”) (NASDAQ: BTRS).

On September 28, 2022, Billtrust announced that it would be acquired by EQT X Fund, an affiliate of private equity firm EQT. According to the announcement, Billtrust stockholders are expected to receive only $9.50 per share for their stock. Notably, prior to the announcement of this proposed sale of the Company to EQT, several analysts had assigned a price target for BTRS shares above the buyout price.

The complaint alleges that Billtrust and certain of the Company’s senior executive officers and directors violated the federal securities laws (including by filing a materially incomplete and misleading proxy statement with the SEC) in connection with the proposed sale of the Company.

Billtrust shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/btrs-holdings-inc/ , for additional information about this action and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
(888) 715 – 1740
www.kaskelalaw.com

Kaskela Law LLC

NASDAQ:BTRS

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
(888) 715 – 1740
www.kaskelalaw.com

More News From Kaskela Law LLC

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Select Medical Holdings Shareholder Buyout and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) on behalf of the company’s shareholders to determine whether the recently announced proposed buyout of SEM shareholders is fair and provides investors with sufficient monetary consideration for their shares.Click here for additional information: https://kaskelalaw.com/case/select-medical/On March 2, 2026, Select Medical announced that it had agreed to...

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Global Business Travel Group Inc. Shareholder Buyout and Encourages Investors to Contact the Firm – GBTG

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”) on behalf of the company’s shareholders to determine whether the recently announced buyout of GBTG shareholders is fair and provides investors with sufficient monetary consideration for their shares. Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, Amex GBT announced that it had agreed to...

TRADEWEB: Kaskela Law Firm Announces Investigation of Tradeweb Markets Inc. (TW) and Encourages Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Tradeweb Markets Inc. (NASDAQ: TW) (“Tradeweb”) on behalf of the company’s investors. The investigation seeks to determine whether Tradeweb and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Tradeweb shareholders who would like to learn more about the investigation and their legal rights and options are encouraged...
Back to Newsroom